CG Oncology CGON Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $4.04M+255% | $1.14M+458% | ||
| $116.64M+42.1% | $82.1M+79.5% | ||
| $73.53M+118% | $33.7M+240% | ||
| $194.81M— | —— | ||
| -$190.77M-66.4% | -$114.67M-107% | ||
| -4,722.1%+5,345pp | -10,067.3%+17,112pp | ||
| $29.78M+11.8% | $26.63M+289% | ||
| -$161M-82.9% | -$88.04M-81.1% | ||
| -3,985%+3,744pp | -7,729.5%+16,097pp | ||
| -$2.07-45.8% | -$1.42+90.9% | ||
| -$189.33M-65.2% | -$114.63M-107% | ||
| -4,686.4%+5,378pp | -10,064.4%+17,106pp | ||
| -$190.77M-66.4% | -$114.67M-107% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does CG Oncology's income statement data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.